Richard Bucala, MD, PhD (@BucalaRichard) header
Richard Bucala, MD, PhD (@BucalaRichard) profile picture

Waldemar Von Zedtwitz Professor of Medicine and Professor of Pathology and of Epidemiology (Microbial Diseases); Chief, Rheumatology, Allergy & Immunology

Yale School of Medicine
Joined February 2021
Photo by Richard Bucala, MD, PhD (@BucalaRichard)Photo by Richard Bucala, MD, PhD (@BucalaRichard)
Richard Bucala, MD, PhD retweeted
DWnews TV Interview with Dr. Richard Bucala | 25th April | topic: World Malaria Day @YaleRheumAller1 @YaleIMed share.ard-zdf-box.de/s/DpWRX…
1
7
Yale School of Medicine Is in the Top Ten in Latest U.S. News Rankings m.yale.edu/cfd7 via @yalemed
4
Richard Bucala, MD, PhD retweeted
The ACR recently released #COVID19 #vaccine guidance & has submitted letters to state leaders urging them to prioritize patients on immunosuppressants in accordance with ACR recommendations. Help us amplify our message → acr.tw/3t1dIV6
A vaccine against malaria: five minutes with . . . Richard Bucala bmj.com/content/bmj/372/bmj.…
2
Richard Bucala, MD, PhD retweeted
Editor's Pick from the March 2021 Arthritis & Rheumatology: Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry by @MilenaGianfran @rheum_covid onlinelibrary.wiley.com/doi/…
Richard Bucala, MD, PhD retweeted
'A Malaria Vaccine Candidate blogs.sciencemag.org/pipelin…
1
1
Richard Bucala, MD, PhD retweeted
First vaccine to fully immunize against malaria builds on pandemic-driven RNA tech academictimes.com/first-vacc… via @academictimes
1
1
5
Richard Bucala, MD, PhD retweeted
Breakthrough made in vaccine against malaria using same tech for COVID-19 @YaleIMed @YaleRheumAller1 @BucalaRichard i24news.tv/en/news/technolog…
1
3